European collaboration for cell- and gene therapies in precision medicine
In brief, in English
This call funds Swedish participation in the EP PerMed JTC 2027 joint call focused on developing and validating innovative cell and gene therapies within precision medicine. Eligible Swedish entities participating in the international EP PerMed partnership can apply.
Written by a model from the publisher's text. The official page is the authority. How data is produced
Vinnova is offering funding for Swedish participation in a call for proposals within the EU partnership European Partnership for Personalised Medicine, EP PerMed, a programme for international collaboration in precision medicine. In November 2026, the partnership will open a call for proposals, JTC 2027, with a focus on developing and validating innovative cell and gene therapies.
Documenti
Cronologia delle modifiche
First seen 20 Nov 2026, last checked 22 Nov 2026. 1 recorded version.
- 20 Nov 2026 · 4905492f5f31